For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| General and administrative costs | 944,538 | |||
| Loss from operations | -944,538 | |||
| Dividends earned on marketable securities held in trust account | 7,306,965 | |||
| Total other income | 7,306,965 | |||
| Net income (loss) | 6,362,427 | |||
| Basic EPS | 0.29 | |||
| Diluted EPS | 0.29 | |||
| Basic Average Shares | 17,250,000 | |||
| Diluted Average Shares | 17,250,000 | |||
Translational Development Acquisition Corp. (TDACW)
Translational Development Acquisition Corp. (TDACW)